MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. (“BMS”) to expand genomics solutions in South Korea by leveraging MGI’s cutting-edge technology.

Is screen time really to blame for poor drawing skills in kids?

Study found that the link between screen viewing and drawing ability in young French children is influenced by socioeconomic factors, rather than a direct causal

January 5, 2024

Methylphenidate may enhance oculomotor function in individuals with multiple sclerosis

A pilot study conducted by Kessler Foundation researchers has shown promising results in the use of methylphenidate to enhance oculomotor function in individuals with multiple

June 26, 2024

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.